Immediate improvement in aphasia 8 years after stroke

Описание: From Glascow, Scotland, 1 week after treatment at the INR in Boca Raton, Florida, filmed in March 2018. Discussion with Edward Tobinick MD. Treatment was performed 8 years after stroke that caused intractable aphasia, hearing and sensory dysfunction and difficulty using the right hand (motor dysfunction) prior to treatment.

A graphic illustration suggesting that chronic neuroinflammation, mediated by excess TNF in the brain, can reversibly inactivate brain circuits necessary for optimal brain function and connectivity.

Additional Information:
Drugs. com: Perispinal Etanercept for Stroke Recovery - 2023 REVIEW http://bit.ly/3KvFJPe
Florida Doctor Gives Stroke Patients a New Shot at Mobility, Independence: https://bit.ly/3phc56k
Edward Tobinick, M.D. Information: https://bit.ly/36JE4Fx
Edward Tobinick, M.D. Google Scholar: https://bit.ly/3heyKvT
On Overcoming Barriers to Neuroinflammation Research (Tobinick, et al): https://bit.ly/3tcxIGf

LEARN MORE: https://www.strokebreakthrough.com/
REQUEST A CONSULTATION TODAY:
SEE MORE STROKE VIDEOS: https://bit.ly/36BqvYx
YOUTUBE CHANNEL: https://bit.ly/3M5HbYk
CALL: +1 (561) 353-9707

60 Minutes Australia "Reverse Stroke" feature, including Dr. Tobinick interview, now with captions -    • Amazing Stroke Recovery: New Stroke Treatm...  

Continuous improvement for 1 year after treatment by Edward Tobinick, M.D.
Dec 8, 2020 — Continuous improvement for 1 year after perispinal etanercept treatment by Edward Tobinick, M.D.
   • Continuous improvement for 1 year after pe...  

Improvement 18 mo. post-stroke after treatment by Edward Tobinick, M.D.
Mar 2, 2020 — Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, ...
   • Improvement 18 mo. post-stroke after treat...  

Edward Tobinick MD on LinkedIn
Edward Tobinick - Institute of Neurological Recovery, Boca Raton, Florida
Edward Lewis Tobinick graduated Phi Beta Kappa and Magna Cum Laude with honors in biology from Brandeis University in Waltham, Massachusetts and received his ...
  / edwardtobinick  

Edward Tobinick - Google Scholar
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease. EL Tobinick, H Gross. BMC neurology 8 (1), 1-9, 2008.
https://scholar.google.com/citations?...

11/11/19 stroke treatment by Edward Tobinick, M.D.
Nov 19, 2019 — 11/19/19 stroke treatment by Edward Tobinick, M.D. Rapid improvements in speech, walking, vision, arm and leg movement 2 years after stroke.
  / 929440460789163  

Edward Tobinick MD Biography
Edward Lewis Tobinick, M.D. is an American physician, inventor, and scientist. He has authored multiple, peer-reviewed, scientific publications in the field ...
https://www.strokebreakthrough.com/dr...

Edward Tobinick Selective TNF Inhibition for Chronic Stroke and TBI
Edward Tobinick MD, founder of the Institute of Neurological Recovery, is a leading innovator in the field of neurological therapeutics.
https://www.tobinick.com/

Edward Tobinick MD on Doximity
Dr. Edward Tobinick, MD - Boca Raton, FL | Internal Medicine
Dr. Edward Tobinick, MD is a board certified internist in Boca Raton, Florida.
https://www.doximity.com/pub/edward-t...

REQUEST A CONSULTATION TODAY:
https://www.strokebreakthrough.com/re...
LEARN MORE: https://www.strokebreakthrough.com/
CALL: +1 (561) 353-9707
SEE MORE STROKE VIDEOS: https://www.strokebreakthrough.com/pa...
YouTube Channel:    / nrimed  

Text, images and video © 2021, INR PLLC, all rights reserved. Disclaimer: Individual results vary, not all patients respond. This treatment is a patented invention of the INR PLLC. Please see https://www.strokebreakthrough.com/ab...

Disclaimer: Individual results vary, not all patients respond. Additional treatment doses may be necessary to maintain the clinical response. Treatment for this indication is off-label. Please see the Terms of Use (http://www.nrimed.com/about/terms-of-.... The method of treatment utilized is a patented invention of the INR®. Issued and pending U.S. and foreign patents, including U.S. patents 8,236,306; 8,349,323; 8,900,583; 9,808,523; Australian patent 2011323616 B2, European patent ES2620749 (T3), etc., all assigned to TACT IP LLC. © 2018 INR PLLC, all rights reserved.